Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CRT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,079
Award facts
- Contract value 100% obligated
- $7,079.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,079.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 6, 2026, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. The contract is non-set-aside and was competitively awarded, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, by January 7, 2026. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The DLA Medical Supply Chain utilizes this indefinite delivery contract vehicle to procure a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—across multiple therapeutic domains to support military treatment facilities, veteran healthcare systems, and other federal medical institutions worldwide. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its established capability to efficiently fulfill government medical procurement requirements through open competition, positioning the company as a critical vendor within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9CRT?
SPE2DR26F9CRT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9CRT worth?
The government has obligated $7,079 on SPE2DR26F9CRT.
Is contract SPE2DR26F9CRT an order under another contract?
Yes. SPE2DR26F9CRT is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CRT competed?
The extent of competition for SPE2DR26F9CRT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award